XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 256,807 $ 305,564
Restricted cash, current 3,329 3,329
Marketable securities 173,883 171,372
Accounts receivable, net 99,765 92,555
Prepaid expenses and other current assets 25,610 20,924
Deferred contract costs, current 44,032 38,584
Total current assets 603,426 632,328
Property and equipment, net 4,068 4,439
Capitalized software, net 32,096 31,388
Operating lease right-of-use assets 4,205 5,691
Restricted cash, non-current 100 659
Deferred contract costs, non-current 34,382 35,790
Strategic investments 10,311 10,311
Intangible assets, net 4,268 5,223
Goodwill 12,646 12,646
Other assets 2,952 2,721
Total assets 708,454 741,196
Current liabilities:    
Accounts payable 3,078 2,506
Accrued expenses and other current liabilities 30,540 27,778
Content costs payable 35,372 40,277
Accrued compensation and benefits 20,151 24,332
Operating lease liabilities, current 3,581 5,825
Deferred revenue, current 315,563 279,414
Total current liabilities 408,285 380,132
Operating lease liabilities, non-current 945 1,124
Deferred revenue, non-current 2,340 3,000
Other liabilities, non-current 390 48
Total liabilities 411,960 384,304
Note 7 – Commitments and contingencies
Stockholders' equity:    
Common stock, $0.00000 par value - 950,000 shares authorized; 153,591,721 and 157,166 shares issued and outstanding as of March 31, 2024, and December 31, 2023, respectively. 2 2
Additional paid-in capital 1,034,603 1,076,508
Accumulated other comprehensive income (loss) (74) 80
Accumulated deficit (738,037) (719,698)
Total stockholders’ equity 296,494 356,892
Total liabilities and stockholders' equity $ 708,454 $ 741,196